This document discusses cardiac arrhythmias including their definitions, mechanisms, classifications, and management. Some key points:
- Arrhythmias refer to abnormal electrical activity of the heart and can involve abnormal impulse formation, conduction, rate, or rhythm. Common mechanisms include accelerated automaticity, triggered activity, and reentry.
- Arrhythmias are classified anatomically based on site of origin or electrocardiographically based on features seen on ECG such as rate, rhythm, and conduction abnormalities.
- Common arrhythmias include sinus tachycardia, atrial fibrillation, supraventricular tachycardia, ventricular tachycardia, and heart block.
- Management depends
1) The document defines wide complex tachycardia as a rhythm with a QRS duration ≥120ms and heart rate >100 bpm.
2) The main causes listed are ventricular tachycardia (80% of cases) and supraventricular tachycardia with aberrancy.
3) Key features that can help differentiate the underlying rhythm include QRS duration, axis, morphology, and the presence or absence of AV dissociation on electrocardiogram.
Basics of Electrocardiography, Arrhythmia & PacemakerPallab Nath
This document provides an overview of electrocardiography (ECG), including basics of the cardiac conduction system, ECG leads and recording methodology, normal ECG waveforms and intervals, cardiac arrhythmias, and pacemakers. Key topics covered include the standard 12-lead ECG, techniques for interpreting rate, rhythm, intervals, and axis, common normal variants and abnormalities, types of arrhythmias including sinus, atrial, and ventricular rhythms, and basics of cardiac pacemaker function. The document serves as an educational guide for understanding ECGs and their clinical applications.
Wide QRS tachycardia requires differentiating between ventricular tachycardia (VT) and supraventricular tachycardia with aberrancy (SVT-A). The document discusses various algorithms and criteria for making this distinction using the electrocardiogram. These include Wellens' criteria, Brugada criteria, Vereckei's aVR algorithm, and analyzing features such as QRS morphology and the presence of atrioventricular dissociation. No single algorithm is perfect, so electrophysiological testing may be needed in some cases to make a definitive diagnosis and guide appropriate treatment.
A 45-year-old female presented with difficulty breathing, palpitations, and sweating for 4 hours. An ECG showed Wolff-Parkinson-White (WPW) syndrome, characterized by a short PR interval, delta wave, and widened QRS complex. WPW is a congenital condition involving an accessory pathway that allows supraventricular impulses to bypass the AV node and activate the ventricles early. Treatment options include antiarrhythmic drugs or radiofrequency ablation to destroy the accessory pathway.
This document provides an overview of the approach to evaluating and diagnosing wide complex tachycardias. It begins with definitions of terms like wide complex tachycardia, ventricular tachycardia, and supraventricular tachycardia. It then discusses the importance of making an accurate diagnosis to avoid inappropriate treatment. Various ECG criteria are presented to help distinguish ventricular from supraventricular rhythms based on features like AV dissociation, QRS morphology, axis, and precordial patterns. Specific criteria for right bundle branch block and left bundle branch block morphologies are also outlined. The document emphasizes taking a stepwise approach and considering clinical history in narrowing the differential diagnosis of wide complex tachycardias.
1. AVNRT and AVRT are types of supraventricular tachycardia involving abnormal pathways for electrical conduction between the atria and ventricles.
2. AVNRT is caused by a reentry circuit within the AV node, while AVRT involves an accessory pathway bypassing the AV node.
3. There are different subtypes of AVNRT and AVRT depending on which pathways are involved in the antegrade and retrograde directions. Typical AVNRT involves a slow-fast pathway while typical AVRT involves orthodromic conduction over an accessory pathway.
1) The document defines wide complex tachycardia as a rhythm with a QRS duration ≥120ms and heart rate >100 bpm.
2) The main causes listed are ventricular tachycardia (80% of cases) and supraventricular tachycardia with aberrancy.
3) Key features that can help differentiate the underlying rhythm include QRS duration, axis, morphology, and the presence or absence of AV dissociation on electrocardiogram.
Basics of Electrocardiography, Arrhythmia & PacemakerPallab Nath
This document provides an overview of electrocardiography (ECG), including basics of the cardiac conduction system, ECG leads and recording methodology, normal ECG waveforms and intervals, cardiac arrhythmias, and pacemakers. Key topics covered include the standard 12-lead ECG, techniques for interpreting rate, rhythm, intervals, and axis, common normal variants and abnormalities, types of arrhythmias including sinus, atrial, and ventricular rhythms, and basics of cardiac pacemaker function. The document serves as an educational guide for understanding ECGs and their clinical applications.
Wide QRS tachycardia requires differentiating between ventricular tachycardia (VT) and supraventricular tachycardia with aberrancy (SVT-A). The document discusses various algorithms and criteria for making this distinction using the electrocardiogram. These include Wellens' criteria, Brugada criteria, Vereckei's aVR algorithm, and analyzing features such as QRS morphology and the presence of atrioventricular dissociation. No single algorithm is perfect, so electrophysiological testing may be needed in some cases to make a definitive diagnosis and guide appropriate treatment.
A 45-year-old female presented with difficulty breathing, palpitations, and sweating for 4 hours. An ECG showed Wolff-Parkinson-White (WPW) syndrome, characterized by a short PR interval, delta wave, and widened QRS complex. WPW is a congenital condition involving an accessory pathway that allows supraventricular impulses to bypass the AV node and activate the ventricles early. Treatment options include antiarrhythmic drugs or radiofrequency ablation to destroy the accessory pathway.
This document provides an overview of the approach to evaluating and diagnosing wide complex tachycardias. It begins with definitions of terms like wide complex tachycardia, ventricular tachycardia, and supraventricular tachycardia. It then discusses the importance of making an accurate diagnosis to avoid inappropriate treatment. Various ECG criteria are presented to help distinguish ventricular from supraventricular rhythms based on features like AV dissociation, QRS morphology, axis, and precordial patterns. Specific criteria for right bundle branch block and left bundle branch block morphologies are also outlined. The document emphasizes taking a stepwise approach and considering clinical history in narrowing the differential diagnosis of wide complex tachycardias.
1. AVNRT and AVRT are types of supraventricular tachycardia involving abnormal pathways for electrical conduction between the atria and ventricles.
2. AVNRT is caused by a reentry circuit within the AV node, while AVRT involves an accessory pathway bypassing the AV node.
3. There are different subtypes of AVNRT and AVRT depending on which pathways are involved in the antegrade and retrograde directions. Typical AVNRT involves a slow-fast pathway while typical AVRT involves orthodromic conduction over an accessory pathway.
Sick sinus syndrome describes dysfunction of the heart's sinoatrial node, which can cause abnormal heart rhythms like bradycardia, tachycardia, and alternating slow and fast rhythms. It is usually caused by non-specific degeneration of the conduction system in older adults. Various types of heart block exist that interfere with conduction in the heart, from first degree involving prolonged PR intervals to third degree or complete heart block where no impulses reach the ventricles. Bundle branch blocks occur when the left or right bundle branch is blocked, delaying conduction and causing characteristic ECG patterns.
Risk stratification in UA and NSTEMI: Why and How?cardiositeindia
This document discusses risk stratification in patients with unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI). It summarizes three risk scores - the TIMI score, PURSUIT score, and GRACE score - and evaluates their ability to predict adverse cardiac outcomes at 30 days and 1 year. The study found that all three scores had fair to good predictive accuracy at 30 days, while the GRACE score was best at predicting outcomes at 1 year. Revascularization was found to provide greater benefit in higher risk patients as classified by these risk scores.
Ventricular tachycardia is a fast heart rhythm originating from the ventricles with a rate over 100 bpm. It is classified based on duration (sustained vs non-sustained), morphology (monomorphic, polymorphic, sinusoidal), and symptoms. Causes include structural heart disease, electrolyte abnormalities, drugs, and prolonged QT interval. Diagnosis involves ECG criteria showing ventricular origin. Treatment depends on hemodynamic stability and may include antiarrhythmic drugs, implantable cardioverter-defibrillator, catheter ablation, or surgery. Recurrent ventricular tachycardia is managed long term with devices, drugs, and treatment of underlying causes.
This document provides a history of the electrocardiogram (EKG/ECG) and describes how it is used to evaluate cardiac electrical activity and identify various cardiac conditions. Some key points:
- The EKG was developed in the late 19th/early 20th century, with scientists like Matteucci, Marey, and Einthoven contributing to its invention and clinical use.
- An EKG records the heart's electrical activity through electrodes on the skin and can be used to detect arrhythmias, ischemia, infarction, and other conditions.
- It analyzes the P wave, QRS complex, ST segment, and T wave to evaluate conduction and identify abnormalities.
This document discusses ECG changes that occur due to cardiac chamber enlargement, including left atrial, right atrial, biatrial, left ventricular, right ventricular, and biventricular abnormalities. For each type of chamber enlargement, the document outlines the mechanisms, diagnostic ECG criteria, and examples of ECG patterns. Key findings include prolonged P waves and biphasic P waves in leads indicating left and right atrial enlargement, increased QRS voltages and ST-T wave changes indicating left ventricular pressure overload, and tall R waves in right-sided leads indicating right ventricular hypertrophy. The document provides a detailed reference for understanding ECG manifestations of different cardiac structural abnormalities.
Tachy Arrhythmias - Approach to ManagementArun Vasireddy
Tachyarrhythmias are disorders of heart rhythm which may present with a tachycardia i.e. a heart rate >100 bpm.
This article provides an overview of tachyarrhythmias in general and goes on to cover the most common tachyarrhythmias in more detail. The acute management of tachyarrhythmias, in an emergency setting, will be covered in the 'Acute' section of the fastbleep website.
Tachyarrhythmias are clinically important as they can precipitate cardiac arrest, cardiac failure, thromboembolic disease and syncopal events. As such, they crop up time and time again in exam papers and on the wards.
Tachyarrhythmias are classified based on whether they have broad or narrow QRS complexes on the ECG. Broad is defined as >0.12s (or more than 3 small squares on the standard ECG). Narrow is equal to or less than 0.12s. Broad QRS complexes are slower ventricular depolarisations that arise from the ventricles. Narrow complexes are ventricular depolarisations initiated from above the ventricles (known as supraventricular). One important exception is when there is a supraventricular depolarisation conducted through a diseased AV node. This will produce wide QRS complexes despite the rhythm being supraventricular in origin.
This document provides an overview of cardiac arrhythmias including their classification, mechanisms, clinical manifestations, diagnostic approaches and management strategies. It discusses various specific arrhythmias in detail such as atrial fibrillation, atrial flutter, supraventricular tachycardia, ventricular arrhythmias, sick sinus syndrome and heart block. Treatment options covered include pharmacological therapies using different classes of antiarrhythmic drugs, procedures like cardiac ablation and use of devices like pacemakers.
This document discusses ECG patterns in congenital heart disease. It begins by outlining the significance of ECG in diagnosing congenital heart defects. It then provides an overview of normal ECG changes in children and how they evolve over time as hemodynamics change. Next, it describes how ECG can help identify situs and ventricular position. It then discusses the characteristic ECG patterns seen in common acyanotic defects like atrial septal defects and ventricular septal defects. It also covers cyanotic defects like transposition of the great arteries. The document provides detailed information on ECG features, associated conditions, complications and evolution over time for many different congenital heart defects.
1. The ECG shows a 45-year-old diabetic man with episodes of palpitations who presents with ventricular trigeminy.
2. Ventricular trigeminy is characterized by ventricular premature beats occurring after every two normal sinus beats with a compensatory pause.
3. Further investigation with Holter monitoring is recommended to better characterize the ventricular arrhythmia and assess for underlying cardiac disease.
1. Right bundle branch block (RBBB) results from a defect in the heart's electrical conduction system where there is a delay or failure of impulses traveling down the right bundle branch.
2. This causes the right ventricle to depolarize more slowly than usual, resulting in a characteristic wide and notched QRS complex on ECG.
3. RBBB is generally not treated unless it progresses to heart block, in which case further testing may be needed.
AV nodal reentrant tachycardia (AVNRT), or atrioventricular nodal reentrant tachycardia, is a type of tachycardia (fast rhythm) of the heart. It is a type of supraventricular tachycardia (SVT), meaning that it originates from a location within the heart above the bundle of His. AV nodal reentrant tachycardia is the most common regular supraventricular tachycardia. It is more common in women than men (approximately 75% of cases occur in females). The main symptom is palpitations. Treatment may be with specific physical maneuvers, medication, or, rarely, synchronized cardioversion. Frequent attacks may require radiofrequency ablation, in which the abnormally conducting tissue in the heart is destroyed.
AVNRT occurs when a reentry circuit forms within or just next to the atrioventricular node. The circuit usually involves two anatomical pathways: the fast pathway and the slow pathway, which are both in the right atrium. The slow pathway (which is usually targeted for ablation) is located inferior and slightly posterior to the AV node, often following the anterior margin of the coronary sinus. The fast pathway is usually located just superior and posterior to the AV node. These pathways are formed from tissue that behaves very much like the AV node, and some authors regard them as part of the AV node.
The fast and slow pathways should not be confused with the accessory pathways that give rise to Wolff-Parkinson-White syndrome (WPW syndrome) or atrioventricular reciprocating tachycardia (AVRT). In AVNRT, the fast and slow pathways are located within the right atrium close to or within the AV node and exhibit electrophysiologic properties similar to AV nodal tissue. Accessory pathways that give rise to WPW syndrome and AVRT are located in the atrioventricular valvular rings. They provide a direct connection between the atria and ventricles, and have electrophysiologic properties similar to ventricular myocardium.
This document summarizes the history and classification of sinus of Valsalva aneurysm (SOVA). Some key points:
- SOVA was first described in 1839 and the first successful repair was in 1956 using cardiopulmonary bypass.
- SOVAs can be congenital or acquired due to various connective tissue/inflammatory disorders.
- The majority originate from the right coronary cusp (77%) and most commonly rupture into the right ventricle (67.9%).
- The classic Sakakibara classification categorizes SOVAs arising from the right coronary cusp into three types based on location of rupture/protrusion. A modified classification exists for non-cor
Ventricular tachycardia can occur due to various causes like acute myocardial infarction, chronic infarction, dilated cardiomyopathy, etc. It is classified as sustained, non-sustained, monomorphic, polymorphic, etc. based on characteristics. Diagnosis involves ECG, echocardiogram, and monitoring. Treatment depends on hemodynamic stability and includes electrical cardioversion, antiarrhythmic drugs like amiodarone, lidocaine, ablation, and ICD implantation in selected cases. Recurrence risk is high in structurally abnormal hearts and prevention involves controlling triggers, antiarrhythmics, and ICDs.
Atrial fibrillation and atrial flutter are types of arrhythmia where the heart beats irregularly. Atrial fibrillation occurs when rapid, irregular electrical signals cause the heart's upper chambers (atria) to beat very fast and irregularly. Atrial flutter is similar but the heart beats fast in a regular pattern. These conditions are diagnosed through electrocardiograms which detect abnormal heart rhythms. Holter monitors and event recorders can also detect arrhythmias over longer periods of time when symptoms occur. Complications include stroke and heart failure, so treatment focuses on rate or rhythm control and preventing clots.
In cases of right atrial enlargement the duration of the P wave hardly changes, but the P-R interval increases, so that the P--R segment ratio falls below the normal range.Left atrial enlargement, on the other hand,does not affect the P-R interval, but the P wave lengthens at the expense of the P-R segment.The result is a- ratio above P-R segment the normal maximal limit of 1.6.In combined atrial enlargement, both P-R interval and P wave are prolonged. It follows that in such cases the ratio may P-R segment
be normal.
This document discusses the Q-T interval on electrocardiograms (ECGs). It defines the Q-T interval as the time from the start of the QRS complex to the end of the T wave. It also discusses how to measure and correct the Q-T interval for heart rate using various formulas. A prolonged corrected Q-T interval increases the risk of ventricular arrhythmias while a shortened interval is associated with atrial and ventricular fibrillation. Causes of a prolonged interval include electrolyte abnormalities, ischemia, increased intracranial pressure, and genetic conditions; causes of a shortened interval include hypercalcemia and genetic conditions.
This document discusses algorithms and ECG parameters for differentiating between types of narrow complex tachycardia, including atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT). Key parameters discussed include the presence of pseudo waves, retrograde P wave morphology and position, and the RP interval. The Jaeggi algorithm uses these parameters to differentiate AVNRT from AVRT based on ECG analysis alone in 76% of cases. Retrograde P wave morphology varies depending on the location of the accessory pathway in cases of AVRT.
Tachycardias are broadly categorized based upon the width of the QRS complex on the electrocardiogram (ECG). A narrow QRS complex (<120 milliseconds) reflects rapid activation of the ventricles via the normal His-Purkinje system, which in turn suggests that the arrhythmia originates above or within the His bundle (ie, a supraventricular tachycardia). The site of origin may be in the sinus node, the atria, the atrioventricular (AV) node, the His bundle, or some combination of these sites. A widened QRS (≥120 milliseconds) occurs when ventricular activation is abnormally slow. The most common reason that a QRS is widened is because the arrhythmia originates below the His bundle in the bundle branches, Purkinje fibers, or ventricular myocardium (eg, ventricular tachycardia). Alternatively, a supraventricular arrhythmia can produce a widened QRS if there are either pre-existing or rate-related abnormalities within the His-Purkinje system (eg, supraventricular tachycardia with aberrancy), or if conduction occurs over an accessory pathway. Thus, wide QRS complex tachycardias may be either supraventricular or ventricular in origin.
1. This document discusses ECG patterns in children and differences compared to adults. It covers developmental changes with age, ventricular dominance patterns in newborns, and ECG findings in various congenital heart diseases.
2. Key differences in children include having a smaller chest size, developmental changes with age including decreasing heart rate and increasing wave durations, and using z-scores instead of adult criteria. Ventricular dominance transitions from right to left dominance in the first year.
3. ECG patterns are described for various congenital heart defects including Tetralogy of Fallot, transposition of the great arteries, Ebstein's anomaly, ventricular septal defects, and Eisenmenger's syndrome. Distinct
This document provides an overview of sinus of Valsalva aneurysm (SOVA). Key points include:
- SOVA is a thin-walled bulge that originates from the aortic sinuses, most commonly the right sinus. It can rupture into the right heart chambers.
- Presentation depends on rupture status - ruptured SOVA causes a continuous murmur while unruptured can cause arrhythmias or embolism. Imaging helps confirm diagnosis.
- Surgery is the standard treatment, involving a median sternotomy, cardiopulmonary bypass, and patch closure of the defect from inside the aorta and heart chambers. Device closure is also possible. Outcomes are generally good but
Cardiac arrhythmia- Dr, Ashok Dutta. Associate professor and senior consultan...Ashok Dutta
This document provides an overview of cardiac arrhythmias including definitions, mechanisms, classifications, and ECG patterns. It discusses abnormal heart rhythms in terms of rate, rhythm, and conduction abnormalities. Common arrhythmias like sinus tachycardia, atrial fibrillation, ventricular tachycardia, and heart blocks are described. Treatment options for arrhythmias include medications, cardioversion, ablation, and pacemakers. Antiarrhythmic drug classifications and their mechanisms of action are also reviewed.
1. Tachyarrhythmias are abnormal heart rhythms with a rate over 100 beats per minute. They can originate from the atria, AV node, or ventricles.
2. Common supraventricular tachycardias include sinus tachycardia, atrial fibrillation, atrial flutter, and AV nodal reentrant tachycardia. Atrial fibrillation is characterized by irregularly irregular rhythm without P waves.
3. Ventricular arrhythmias include premature ventricular complexes, ventricular tachycardia, and ventricular fibrillation. Polymorphic ventricular tachycardia can degenerate into ventricular fibrillation and requires immediate defibrillation.
Sick sinus syndrome describes dysfunction of the heart's sinoatrial node, which can cause abnormal heart rhythms like bradycardia, tachycardia, and alternating slow and fast rhythms. It is usually caused by non-specific degeneration of the conduction system in older adults. Various types of heart block exist that interfere with conduction in the heart, from first degree involving prolonged PR intervals to third degree or complete heart block where no impulses reach the ventricles. Bundle branch blocks occur when the left or right bundle branch is blocked, delaying conduction and causing characteristic ECG patterns.
Risk stratification in UA and NSTEMI: Why and How?cardiositeindia
This document discusses risk stratification in patients with unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI). It summarizes three risk scores - the TIMI score, PURSUIT score, and GRACE score - and evaluates their ability to predict adverse cardiac outcomes at 30 days and 1 year. The study found that all three scores had fair to good predictive accuracy at 30 days, while the GRACE score was best at predicting outcomes at 1 year. Revascularization was found to provide greater benefit in higher risk patients as classified by these risk scores.
Ventricular tachycardia is a fast heart rhythm originating from the ventricles with a rate over 100 bpm. It is classified based on duration (sustained vs non-sustained), morphology (monomorphic, polymorphic, sinusoidal), and symptoms. Causes include structural heart disease, electrolyte abnormalities, drugs, and prolonged QT interval. Diagnosis involves ECG criteria showing ventricular origin. Treatment depends on hemodynamic stability and may include antiarrhythmic drugs, implantable cardioverter-defibrillator, catheter ablation, or surgery. Recurrent ventricular tachycardia is managed long term with devices, drugs, and treatment of underlying causes.
This document provides a history of the electrocardiogram (EKG/ECG) and describes how it is used to evaluate cardiac electrical activity and identify various cardiac conditions. Some key points:
- The EKG was developed in the late 19th/early 20th century, with scientists like Matteucci, Marey, and Einthoven contributing to its invention and clinical use.
- An EKG records the heart's electrical activity through electrodes on the skin and can be used to detect arrhythmias, ischemia, infarction, and other conditions.
- It analyzes the P wave, QRS complex, ST segment, and T wave to evaluate conduction and identify abnormalities.
This document discusses ECG changes that occur due to cardiac chamber enlargement, including left atrial, right atrial, biatrial, left ventricular, right ventricular, and biventricular abnormalities. For each type of chamber enlargement, the document outlines the mechanisms, diagnostic ECG criteria, and examples of ECG patterns. Key findings include prolonged P waves and biphasic P waves in leads indicating left and right atrial enlargement, increased QRS voltages and ST-T wave changes indicating left ventricular pressure overload, and tall R waves in right-sided leads indicating right ventricular hypertrophy. The document provides a detailed reference for understanding ECG manifestations of different cardiac structural abnormalities.
Tachy Arrhythmias - Approach to ManagementArun Vasireddy
Tachyarrhythmias are disorders of heart rhythm which may present with a tachycardia i.e. a heart rate >100 bpm.
This article provides an overview of tachyarrhythmias in general and goes on to cover the most common tachyarrhythmias in more detail. The acute management of tachyarrhythmias, in an emergency setting, will be covered in the 'Acute' section of the fastbleep website.
Tachyarrhythmias are clinically important as they can precipitate cardiac arrest, cardiac failure, thromboembolic disease and syncopal events. As such, they crop up time and time again in exam papers and on the wards.
Tachyarrhythmias are classified based on whether they have broad or narrow QRS complexes on the ECG. Broad is defined as >0.12s (or more than 3 small squares on the standard ECG). Narrow is equal to or less than 0.12s. Broad QRS complexes are slower ventricular depolarisations that arise from the ventricles. Narrow complexes are ventricular depolarisations initiated from above the ventricles (known as supraventricular). One important exception is when there is a supraventricular depolarisation conducted through a diseased AV node. This will produce wide QRS complexes despite the rhythm being supraventricular in origin.
This document provides an overview of cardiac arrhythmias including their classification, mechanisms, clinical manifestations, diagnostic approaches and management strategies. It discusses various specific arrhythmias in detail such as atrial fibrillation, atrial flutter, supraventricular tachycardia, ventricular arrhythmias, sick sinus syndrome and heart block. Treatment options covered include pharmacological therapies using different classes of antiarrhythmic drugs, procedures like cardiac ablation and use of devices like pacemakers.
This document discusses ECG patterns in congenital heart disease. It begins by outlining the significance of ECG in diagnosing congenital heart defects. It then provides an overview of normal ECG changes in children and how they evolve over time as hemodynamics change. Next, it describes how ECG can help identify situs and ventricular position. It then discusses the characteristic ECG patterns seen in common acyanotic defects like atrial septal defects and ventricular septal defects. It also covers cyanotic defects like transposition of the great arteries. The document provides detailed information on ECG features, associated conditions, complications and evolution over time for many different congenital heart defects.
1. The ECG shows a 45-year-old diabetic man with episodes of palpitations who presents with ventricular trigeminy.
2. Ventricular trigeminy is characterized by ventricular premature beats occurring after every two normal sinus beats with a compensatory pause.
3. Further investigation with Holter monitoring is recommended to better characterize the ventricular arrhythmia and assess for underlying cardiac disease.
1. Right bundle branch block (RBBB) results from a defect in the heart's electrical conduction system where there is a delay or failure of impulses traveling down the right bundle branch.
2. This causes the right ventricle to depolarize more slowly than usual, resulting in a characteristic wide and notched QRS complex on ECG.
3. RBBB is generally not treated unless it progresses to heart block, in which case further testing may be needed.
AV nodal reentrant tachycardia (AVNRT), or atrioventricular nodal reentrant tachycardia, is a type of tachycardia (fast rhythm) of the heart. It is a type of supraventricular tachycardia (SVT), meaning that it originates from a location within the heart above the bundle of His. AV nodal reentrant tachycardia is the most common regular supraventricular tachycardia. It is more common in women than men (approximately 75% of cases occur in females). The main symptom is palpitations. Treatment may be with specific physical maneuvers, medication, or, rarely, synchronized cardioversion. Frequent attacks may require radiofrequency ablation, in which the abnormally conducting tissue in the heart is destroyed.
AVNRT occurs when a reentry circuit forms within or just next to the atrioventricular node. The circuit usually involves two anatomical pathways: the fast pathway and the slow pathway, which are both in the right atrium. The slow pathway (which is usually targeted for ablation) is located inferior and slightly posterior to the AV node, often following the anterior margin of the coronary sinus. The fast pathway is usually located just superior and posterior to the AV node. These pathways are formed from tissue that behaves very much like the AV node, and some authors regard them as part of the AV node.
The fast and slow pathways should not be confused with the accessory pathways that give rise to Wolff-Parkinson-White syndrome (WPW syndrome) or atrioventricular reciprocating tachycardia (AVRT). In AVNRT, the fast and slow pathways are located within the right atrium close to or within the AV node and exhibit electrophysiologic properties similar to AV nodal tissue. Accessory pathways that give rise to WPW syndrome and AVRT are located in the atrioventricular valvular rings. They provide a direct connection between the atria and ventricles, and have electrophysiologic properties similar to ventricular myocardium.
This document summarizes the history and classification of sinus of Valsalva aneurysm (SOVA). Some key points:
- SOVA was first described in 1839 and the first successful repair was in 1956 using cardiopulmonary bypass.
- SOVAs can be congenital or acquired due to various connective tissue/inflammatory disorders.
- The majority originate from the right coronary cusp (77%) and most commonly rupture into the right ventricle (67.9%).
- The classic Sakakibara classification categorizes SOVAs arising from the right coronary cusp into three types based on location of rupture/protrusion. A modified classification exists for non-cor
Ventricular tachycardia can occur due to various causes like acute myocardial infarction, chronic infarction, dilated cardiomyopathy, etc. It is classified as sustained, non-sustained, monomorphic, polymorphic, etc. based on characteristics. Diagnosis involves ECG, echocardiogram, and monitoring. Treatment depends on hemodynamic stability and includes electrical cardioversion, antiarrhythmic drugs like amiodarone, lidocaine, ablation, and ICD implantation in selected cases. Recurrence risk is high in structurally abnormal hearts and prevention involves controlling triggers, antiarrhythmics, and ICDs.
Atrial fibrillation and atrial flutter are types of arrhythmia where the heart beats irregularly. Atrial fibrillation occurs when rapid, irregular electrical signals cause the heart's upper chambers (atria) to beat very fast and irregularly. Atrial flutter is similar but the heart beats fast in a regular pattern. These conditions are diagnosed through electrocardiograms which detect abnormal heart rhythms. Holter monitors and event recorders can also detect arrhythmias over longer periods of time when symptoms occur. Complications include stroke and heart failure, so treatment focuses on rate or rhythm control and preventing clots.
In cases of right atrial enlargement the duration of the P wave hardly changes, but the P-R interval increases, so that the P--R segment ratio falls below the normal range.Left atrial enlargement, on the other hand,does not affect the P-R interval, but the P wave lengthens at the expense of the P-R segment.The result is a- ratio above P-R segment the normal maximal limit of 1.6.In combined atrial enlargement, both P-R interval and P wave are prolonged. It follows that in such cases the ratio may P-R segment
be normal.
This document discusses the Q-T interval on electrocardiograms (ECGs). It defines the Q-T interval as the time from the start of the QRS complex to the end of the T wave. It also discusses how to measure and correct the Q-T interval for heart rate using various formulas. A prolonged corrected Q-T interval increases the risk of ventricular arrhythmias while a shortened interval is associated with atrial and ventricular fibrillation. Causes of a prolonged interval include electrolyte abnormalities, ischemia, increased intracranial pressure, and genetic conditions; causes of a shortened interval include hypercalcemia and genetic conditions.
This document discusses algorithms and ECG parameters for differentiating between types of narrow complex tachycardia, including atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT). Key parameters discussed include the presence of pseudo waves, retrograde P wave morphology and position, and the RP interval. The Jaeggi algorithm uses these parameters to differentiate AVNRT from AVRT based on ECG analysis alone in 76% of cases. Retrograde P wave morphology varies depending on the location of the accessory pathway in cases of AVRT.
Tachycardias are broadly categorized based upon the width of the QRS complex on the electrocardiogram (ECG). A narrow QRS complex (<120 milliseconds) reflects rapid activation of the ventricles via the normal His-Purkinje system, which in turn suggests that the arrhythmia originates above or within the His bundle (ie, a supraventricular tachycardia). The site of origin may be in the sinus node, the atria, the atrioventricular (AV) node, the His bundle, or some combination of these sites. A widened QRS (≥120 milliseconds) occurs when ventricular activation is abnormally slow. The most common reason that a QRS is widened is because the arrhythmia originates below the His bundle in the bundle branches, Purkinje fibers, or ventricular myocardium (eg, ventricular tachycardia). Alternatively, a supraventricular arrhythmia can produce a widened QRS if there are either pre-existing or rate-related abnormalities within the His-Purkinje system (eg, supraventricular tachycardia with aberrancy), or if conduction occurs over an accessory pathway. Thus, wide QRS complex tachycardias may be either supraventricular or ventricular in origin.
1. This document discusses ECG patterns in children and differences compared to adults. It covers developmental changes with age, ventricular dominance patterns in newborns, and ECG findings in various congenital heart diseases.
2. Key differences in children include having a smaller chest size, developmental changes with age including decreasing heart rate and increasing wave durations, and using z-scores instead of adult criteria. Ventricular dominance transitions from right to left dominance in the first year.
3. ECG patterns are described for various congenital heart defects including Tetralogy of Fallot, transposition of the great arteries, Ebstein's anomaly, ventricular septal defects, and Eisenmenger's syndrome. Distinct
This document provides an overview of sinus of Valsalva aneurysm (SOVA). Key points include:
- SOVA is a thin-walled bulge that originates from the aortic sinuses, most commonly the right sinus. It can rupture into the right heart chambers.
- Presentation depends on rupture status - ruptured SOVA causes a continuous murmur while unruptured can cause arrhythmias or embolism. Imaging helps confirm diagnosis.
- Surgery is the standard treatment, involving a median sternotomy, cardiopulmonary bypass, and patch closure of the defect from inside the aorta and heart chambers. Device closure is also possible. Outcomes are generally good but
Cardiac arrhythmia- Dr, Ashok Dutta. Associate professor and senior consultan...Ashok Dutta
This document provides an overview of cardiac arrhythmias including definitions, mechanisms, classifications, and ECG patterns. It discusses abnormal heart rhythms in terms of rate, rhythm, and conduction abnormalities. Common arrhythmias like sinus tachycardia, atrial fibrillation, ventricular tachycardia, and heart blocks are described. Treatment options for arrhythmias include medications, cardioversion, ablation, and pacemakers. Antiarrhythmic drug classifications and their mechanisms of action are also reviewed.
1. Tachyarrhythmias are abnormal heart rhythms with a rate over 100 beats per minute. They can originate from the atria, AV node, or ventricles.
2. Common supraventricular tachycardias include sinus tachycardia, atrial fibrillation, atrial flutter, and AV nodal reentrant tachycardia. Atrial fibrillation is characterized by irregularly irregular rhythm without P waves.
3. Ventricular arrhythmias include premature ventricular complexes, ventricular tachycardia, and ventricular fibrillation. Polymorphic ventricular tachycardia can degenerate into ventricular fibrillation and requires immediate defibrillation.
The document discusses various types of arrhythmias that may occur during anesthesia including narrow and broad complex arrhythmias. It defines arrhythmia and outlines the conduction pathways in the heart. For narrow complex arrhythmias it describes sinus arrhythmias, premature atrial contractions, sinus bradycardia, sinus tachycardia, junctional tachycardia, atrial flutter and fibrillation. For broad complex arrhythmias it covers ventricular ectopy, ventricular tachycardia and fibrillation. Management strategies are provided for selected arrhythmias.
This document provides an overview of tachyarrhythmias and their mechanisms. It discusses the normal cardiac conduction system and describes how abnormalities can lead to arrhythmias via mechanisms like accelerated automaticity, triggered activity, and reentry. It then focuses on atrial fibrillation, describing its classification, causes, diagnosis, and treatment approaches like rate control and anticoagulation based on stroke risk scores. The document emphasizes the importance of evaluating hemodynamic stability and controlling heart rate for arrhythmia patients.
Cardiac rhythm disorders in neonates can include sinus arrhythmias, tachyarrhythmias like atrial tachycardia and supraventricular tachycardia, and ventricular arrhythmias like premature ventricular contractions and ventricular tachycardia. The document discusses how to read an ECG, defines various normal and abnormal rhythms like sinus bradycardia, and outlines their evaluation and treatment approaches. Genetic arrhythmia syndromes are also mentioned.
ecg basics made easy, with description of most common ecg types especially in emergency situation.
easy to memorize points and mnemonics included.
approach to ecg diagnosis.
sample ecgs.
Cardiac arrhythmias are abnormalities in the heart's rhythm. There are two main types: bradycardia, a slow heart rate, and tachycardia, a fast heart rate. Various arrhythmias are described including sinus bradycardia, heart block, atrial fibrillation, atrial flutter, AV nodal reentry tachycardia, ventricular fibrillation, and ventricular tachycardia. Treatment depends on the type of arrhythmia and may include medication, cardioversion, ablation, or pacemaker implantation. Diagnosis involves ECG, echocardiogram, blood tests, and other cardiac tests. Lifestyle changes and avoiding arrhythmia triggers can help management.
Tachyarrhythmias 2020 (for the undergraduates)salah_atta
This document provides an overview of tachyarrhythmias. It defines tachyarrhythmias as abnormal heart rhythms with a heart rate exceeding 100 beats per minute. The document classifies and describes various types of tachyarrhythmias including extrasystoles, sinus tachycardia, supraventricular tachycardias such as AV nodal reentrant tachycardia, atrial fibrillation, and ventricular tachycardias. It discusses the mechanisms, clinical presentations, diagnostic tools and management options for these arrhythmias.
Atrial flutter is an abnormal heart rhythm where the atria beat too fast, usually between 240-340 beats per minute. It often occurs in patients with underlying heart conditions that cause enlargement or damage to the atria, such as rheumatic heart disease, congenital heart disease, or COPD. Common symptoms include palpitations, chest discomfort, and fatigue. Treatment options include medications to slow the heart rate or restore normal rhythm, cardioversion, catheter ablation, or implanting a pacemaker.
Atrial flutter is an abnormal heart rhythm where the atria beat too fast, usually between 240-340 beats per minute. It often occurs in patients with underlying heart conditions that cause enlargement or damage to the atria, such as rheumatic heart disease, congenital heart disease, or COPD. Common symptoms include palpitations, chest discomfort, and fatigue. Treatment options include medications to slow the heart rate or restore normal rhythm, cardioversion, catheter ablation, or implanting a pacemaker.
A comprehensive approach to Atrial Fibrillation. Everything you need to know about Atrial fibrillation. Including recent 2014 AHA guidelines of management.
The document defines and classifies different types of arrhythmias. It discusses the etiology, symptoms, electrocardiogram characteristics and treatment options for various arrhythmias including sinus arrhythmia, atrial fibrillation, ventricular tachycardia, premature contractions, and more. Anti-arrhythmia medications are also categorized based on their mechanisms of action.
This document defines and discusses the management of supraventricular tachyarrhythmias. It begins by defining terms like tachyarrhythmia, tachycardia, and supraventricular tachyarrhythmia. It then discusses various types of supraventricular tachycardias that arise from different areas of the heart including the sinoatrial node, atrioventricular node, atria, and accessory pathways. The document provides guidance on clinical evaluation, ECG patterns, mechanisms, and treatment approaches for common supraventricular tachycardias such as AV nodal reentrant tachycardia, AV reentrant tachycardia, atrial fibrillation, atrial flutter, and atrial
An arrhythmia is an irregular heartbeat that occurs when the heart's electrical signals don't work properly, causing the heart to beat too fast, too slow, or irregularly. Some key types discussed include sinus tachycardia, sinus bradycardia, premature atrial contractions, atrial flutter, atrial fibrillation, supraventricular tachycardia, ventricular tachycardia, and heart block. Causes can include direct damage to the conduction system, inflammation, electrolyte imbalances, and drugs. Treatment depends on the specific type but may include medications, catheter ablation, cardioversion, or pacemaker implantation.
This document presents information on various types of atrial arrhythmias. It discusses premature atrial complexes, atrial tachycardia, multifocal atrial tachycardia, atrial flutter, atrial fibrillation, and wandering atrial pacemaker. For each type, it covers etiology, characteristics, and treatment approaches. The document is presented by Baby Haokip from the College of Nursing, NEIGRIHMS.
This document provides an overview of cardiac arrhythmias, including definitions and descriptions of normal sinus rhythm and various arrhythmias. It discusses the cardiac conduction system and mechanisms that can cause arrhythmias, such as abnormal impulse formation or conduction. Specific arrhythmias summarized include sinus bradycardia, sinus tachycardia, premature atrial contractions, supraventricular tachycardia, atrial fibrillation, atrial flutter, and atrial tachycardia. For each arrhythmia, the document provides information on heart rate, rhythm, P wave presence/morphology, and other ECG characteristics.
This document discusses wide complex tachycardias and how to differentiate them based on electrocardiogram (ECG) findings. It provides details on what makes a complex narrow or wide, types of wide complex tachycardias including ventricular tachycardia and supraventricular tachycardia, and ECG criteria to help determine the source and mechanism such as the presence or absence of RS complexes and their intervals. Morphologic criteria on the ECG and algorithms like the ACC algorithm are presented to aid in differential diagnosis.
This document discusses the electrical conduction system of the heart and how to evaluate electrocardiograms (ECGs). It begins by describing the four chambers of the heart and how electrical activity drives mechanical contractions. It then explains how to analyze different parts of the ECG waveform and identifies common arrhythmias like sinus tachycardia, atrial fibrillation, and ventricular tachycardia. Causes, characteristics, and treatments of various arrhythmias are provided. The document serves as a guide for veterinarians to interpret ECGs and diagnose cardiac arrhythmias in animals.
Its crucial to diagnose arrythmias quickly and treat it promptly.
Here i have made small attempt to diagnose tachyarrythmias briefly and proceeds with its immediate managenent..
Difficulties in Transradial Intervention ( TRI).Ashok Dutta
Difficulties in transradial intervention include failure to puncture the radial artery, radial artery spasm, tortuosity or loops in the radial or brachial arteries, use of smaller catheters, difficult coronary cannulation, and challenges during percutaneous coronary intervention. Proper catheter selection based on artery size and anatomy, use of adjunct devices like buddy wires, and deep intubation can help maximize support during difficult cases. Angiography may be needed to guide wiring and balloon crossing in tortuous vessels, and stenting can seal aortic dissections involving the coronary ostium.
This document discusses the management of aortic regurgitation. It begins by outlining factors to consider before starting treatment, including the severity of regurgitation and presence of other valve diseases or comorbidities. Medical management is indicated for severe regurgitation or moderate regurgitation with symptoms and involves controlling hypertension, limiting activity, and using vasodilators, diuretics, and other drugs. Surgical management involves aortic valve replacement. The document then discusses treatment options in more detail and provides guidelines on managing acute regurgitation, regurgitation in pregnancy, and other special situations.
Heart Failure(HFrEF) management- an Overview Ashok Dutta
This document provides an overview of heart failure management. It defines heart failure and describes its types and classifications. Symptoms include dyspnea and fatigue while signs include circulatory congestion or hypoperfusion. Treatment involves establishing a diagnosis, determining risk factors and severity, and taking a multidisciplinary approach. The main treatment goals are reducing mortality and morbidity by modifying risks, preventing disease progression, and improving quality of life. Guideline directed medical therapy includes diuretics, ACE inhibitors, beta blockers, MRAs, ARNIs, and SGLT2 inhibitors. Device therapies like ICDs and CRT can be used, and management depends on the ACC/AHA stages of heart failure.
This document discusses percutaneous coronary intervention (PCI) stenting performed by Dr. Ashok Dutta on a 65-year-old male patient with a medical history of hypertension, diabetes, and reduced ejection fraction of 55% who presented with lesions in the medial and proximal left circumflex artery. The procedure involved wiring and predilation of the posterior descending artery and proximal left circumflex, positioning stents in both vessels so their proximal edges touched at the carina, simultaneous inflation of both stents at nominal pressure, pulling the stent balloons back 1-2 mm and high pressure inflation of both balloons at 18 atm, resulting in successful stenting.
This document discusses some of the difficulties that can arise during transradial intervention (TRI) and percutaneous coronary intervention (PCI) via the radial artery approach. It outlines potential challenges with radial artery puncture and anatomy, coronary cannulation, and using larger guide catheters for TRI compared to transfemoral intervention. The document also discusses strategies for managing difficult PCI situations like tortuous vessels, calcified lesions, bifurcation lesions, chronic total occlusions, and aorto-ostial dissections that may occur more commonly with TRI.
Basic of PCI through Trans Radial RouteAshok Dutta
1. The document discusses the basics of percutaneous coronary intervention (PCI) through the transradial approach. It covers the history, access routes, procedural steps, guide catheter selection, complications and tips for successful PCI.
2. Key points include that the radial approach has a narrow pathway but fewer complications compared to the femoral approach. Guide catheter size selection depends on the vessel diameter and intended devices. Wiring, balloon angioplasty, stenting and post-dilatation are the standard steps of PCI.
3. Complications include dissection, perforation and stent malapposition. Tips provided to prevent complications and ensure procedural success include proper guide catheter and device selection, gentle manipulation, and frequent
TransUlnar approach - our experience in nhf . Dr. Ashok DuttaAshok Dutta
1) The study compares the transulnar approach (TUA) to coronary angiography and angioplasty with the traditional transradial approach (TRA) in Bangladeshi patients, with the goal of assessing safety, efficacy, and procedural factors of both approaches.
2) Over 12 months, 225 patients underwent TUA while 229 underwent TRA. Successful cannulation was higher with TRA (92.14% vs 81.72% for TUA), but complications were lower for TUA.
3) Procedural times, radiation exposure, and findings during coronary angiography were generally similar between the two groups. Loss of arterial pulse was lower for TUA both during hospitalization and follow-up.
Trans Radial Intervention- Tips & tricks . Dr. Ashok Dutta. Associate profes...Ashok Dutta
This document provides tips and tricks for performing transradial interventions (TRI). It discusses patient selection, positioning, arterial access, and overcoming challenges like loops in the radial or brachiocephalic arteries. Catheter selection principles are outlined for left, right, and bypass graft cannulation. The Tiger and Judkins catheters are recommended workhorses, while the Amplatz and EBU catheters can help with difficult anatomy. Proper manipulation techniques are described to engage coronary arteries. Overall, the document offers guidance on technical aspects of TRI to optimize success and minimize complications.
This document provides guidelines and information on hypertension including blood pressure levels for treating hypertension, classifications of blood pressure levels, comparisons of different drug treatments, and recommendations for treatment. It discusses optimal blood pressure is below 115/75, classifications for hypertension, borderline hypertension, and non-optimal blood pressure. It also compares different drug combinations and recommendations from clinical guidelines.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
2. AXIOM
• All Rhythm Interpretation must be correlated with sign,
symptoms and patients condition….
“Treat the patient,
NOT the monitor”.
Because sometimes artifact may mimic arrhythmia-
Straight line ECG/Asystole- loss of chest lead contact/connection,
vibration – may mimic VT/VF.
Speed of recording ECG- Bradycardia, tachycardia.
3. Arrhythmia
Definition
• Arrhythmia –means
abnormal electrical
activity of the heart.
It may be abnormality in
impulse formation or
it’s conduction
Abnormality in
Rate ( HR=60-100/min),
Rhythm (normal sinus, may be
atrial ,nodal/junctional, ventricular)
Conduction
(SA,AVN,BBB,IVCD)
4. Mechanisms of Cardiac Arrhythmias
Mechanisms of bradicardia:
Sinus bradycardia is a result of abnormally slow
automaticity while bradycardia due to AV block is
caused by abnormal conduction within the AV node or
His bundle, the distal AV conduction system.
Mechanisms generating tachycardia include:
- Accelerated automaticity- S.T. & Accellerated Junctional Tachy
- Triggered activity- ACS setting
- Re-entry (or circus movements)- most common
mechanism- SVT, A. fluttar, scar VT, SANRT.
5. The original concept of Coumel on the left (a), and its generally well-
known final form (b), as the triangle of Coumel, explaining
how the interaction of substrate, triggers and the autonomic
nervous system are important in arrhythmogenesis.
6. Re-entry (or circus movement)
Mechanism of Arrhythmia
• The mechanism of re-entry occurs when a 'ring' of cardiac
tissue having 2 different pathway surrounds an in-excitable
core e.g. in a region of scarred myocardium.
• Alfa/fast pathway is rapid conducting & slow recovery and
• Beta pathway/slow pathway is slow conducting and rapid
recovery .
7. Mechanism of Arrhythmia- Re-entry
SVT, A. flutter, VT.
APC-
Conducted through slow
path because fast path is
refractory
When APC
at appropriate time & site-
Re-enterant
Tachycardia
10. Tachyarrhythmia-ECG Dx.
Atrial rate in supraventricular tachyarrhythmia
(400-300-200-150 bpm)-
AF atrial rate 400+/-100 (300-500) bpm,
A. flutter it’s 300+/- 100 (200-400),
SVT(AVNRT/AVRT) atrial rate 200 +/- 50(150-250) bpm,
Sinus tachycardia – 150+/-50 (100-200) bpm.
All SV tachy – NCT if not aberrantly conducted.
All V Tachy- are WCT- except Fascicular VT, VT close to HB.
Irregular tachy- AF, A flutter with variable AVB, MAT, VF, TdP.
12. General approach to Tachyarrhythmia
• Group-1. DC-shock
• Patients with Cardiac arrest.
• Group-2. DC shock ( Except- Chr.AF)
• Patients with signs of severe hemodynamic
compromise (hemodynamically unstable).
• Group-3. Medical Mx
• Patient without hemodynamic compromise
(stable patients).
13. Vaughan William’s Classification of antiarrhythmic Drugs
based on Drug Action
CLASS ACTION DRUGS
I. Sodium Channel Blockers
1A.
Moderate phase 0 depression and slowed
conduction (2+); prolong repolarization
Quinidine,
Procainamide,
Disopyramide
1B.
Minimal phase 0 depression and slow
conduction (0-1+); shorten repolarization **Lidocaine
1C.
Marked phase 0 depression and slow
conduction (4+); little effect on
repolarization
** propafenone,
Flecainide
II. Beta-Adrenergic Blockers Propranolol, esmolol**
III. K+ Channel Blockers
(prolong repolarization)
Amiodarone**,
Sotalol**, Ibutilide
IV. Calcium Channel Blockade Verapamil**, Diltiazem
V Increase parasympathetic activity Digoxin**, Adenosin**
14. Classification of Antiarrhythmics.
Acts on i) ATRIAL ,
ii) VENTRICULAR
iii) ACCESSORY
PATHWAY.
Class I and III
AV nodal dependant arrhythmia
Class II, IV, V
(BB,CCB,Digoxin & Adenosine.
All anti-arrhythmic drugs are pro-arrhythmic except BB.
All are negative chronotropic.
All are negative ionotropic except digoxin.
class I, IV > class-III
18. How ECG monitor can help?
ST, SVT,AF-FVR
Rate-rhythm. Increase the gain and speed
19. SV- tachy Differentiation
SV- Tachycardia
ECG Remarks
AVNRT Rapid Rate (150-250).
No P wave.
Normal QRS.
Common in Young people.
Episodic, rapid onset, rapid
recovery.Usually recurrent.
AVRT Do Do
Atrial Flutter Saw tooth appearance of P waves,
usually 2:1 AV conduction.
Atrial Rate usually around 300/mint.200-400 bpm
QRS is normal
S/S and Rx like A.F with Fast VR
Atrial
Fibrillation
Irregularly irregular Rhythm.
Normal P is absent, Fibrillatory P
(abnormal, small, bizarre and variable size-shape),
QRS is usually normal.
Cardiac or extra cardiac
causes.
21. S. Arrhythmia
Sinus arrhythmia of young man and children.
Respiratory or non-respiratory variation of HR .
In inspiration rate is higher .
Variation of HR > 10 % .
It indicates good autonomic n. system & good SA node.
*
22. Sinus arrhythmia of young man . Respiratory or nonrespiratory variation of HR .
In inspiration rate is higher . Variation of HR > 10 % .
23. Sinus Pause
Cause: SSS.
S.A BLOCK
• PP/RR interval is exactly the
double of normal PP/RR.
S. ARREST
• Not double.
24. Atrial Arrhythmias
Atrial Ectopic/APC/PAC ( Premature Atrial complex, not contraction).
A. Tachycardia :- Paroxysmal A.T(PAT),
MAT( Multifocal Atrial Tachycardia),
Incessant A T
A. Flutter.
A.Fibrillation.
APC
A.Tachy.
A.F
A.flutter
25. (APC)
It is earlier than next sinus beat ( so premature),
Morphology of P is different from sinus P.
Morphology of the QRS complex is normal as that from sinus.
26. APC in Bigeminy form
APC – after every normal Sinus Complex. Atrial Bigeminy.
27. PVC/VPC – occurs earlier than expected , no P wave, QRS is wide, T
wave is in opposite to mean QRS . In bigeminy form (each of the PVC is
paired with one normal complex).
PVC in trigeminy form.
31. A.T.D/D SVT.
N.B. Don’t confuse with AF with FVR. Look at the monitor.
In AF HR will be variable, in SVT HR – fixed/regular.
32. Atrial Fibrillation.
Disorganised atrial activity and irregular AV
conduction.
International consensus on nomenclature and
classification of AF:
Initial ( First detected) event.
Paroxysmal that terminates spontaneously within 48 hrs. it may recurs.
Persistent – not self limiting, and lasting >7 days or after cardio version.
Permanent( established)- may or may not be terminated or
relapse after cardio version.
(This classification is for guideline of therapy).
33. Atrial Fibrillation ( A.F) with fast ventricular rate.
P waves are absent.
Low amplitude fibrillatory waves .
RR intervals at first glance looks regular but, on closure inspection they are
irregular .
ST-T changes are nonspecific due tachycardia.
35. Management of A.F
Control of Ventricular Rate , class-II /IV.
(BB,CCB,digoxin).
Revert to Sinus Rhythm by DC, Class-I,III
( amiodarone, propafenone).
Maintenance of SR -Class I,III
Anticoagulation.
DC shock.
36. Anticoagulation for AF
Risk Level Risk Factors Therapeutic Guideline
Low Risk Age<65 yrs
No additional risk factor
Aspirin 325 mg/day
Intermediate Risk Age 65-75 yrs
DM
CAD
For 1 Risk Factor-
Aspirin 325 mg/day.
For 2 Risk factors-
Warfarin with target INR
2.5 ( range=2.0-3.0)
High Risk Age >75 yrs.
H/O HTN
LVD
MVD
Prosthetic Heart Valve
H/O CVD ,TIA or systemic
embolism.
More than 1
intermediate risk factors
For any one risk factor-
Warfarin with target INR as
above.
38. SVT- it may be AV nodal reentry tachycardia- AVNRT ( 80% ) or AV (
atrioventricular) reentry tachycardia- AVRT ( 20 %) . AVRT is less
common and it occurs due to accessory pathway ( WPW syndrome ) .
WPW syndrome . Q in inferior leads is not due to OMI.
39. Sign-symptoms of SVT
• Palpitation.
• Dizziness, Blurring vision.
• Vertigo.
• Chest Pain ( due to reduced coronary flow).
• Sweating. Cold –clammy extremities.
• Pre-syncope ( due to reduced cerebral circulation)
• Syncope ( due to reduced cerebral circulation)
• Rapid onset , may suddenly disappears without Rx
or by vomiting.
43. V.T
Salvos of 3-5 consecutive PVCs
Nonsustained VT – consecutive 6 PVCs upto < 30 sec.
Sustained- succession of PVCs >30 sec at
@>=100/mint.
Monomorphic Vs. polymorphic ( Pleomorphic) VT.
And Torsade de pointes.
Differentiation between VT and SVT with aberrant
conduction.
44. Causes of VT
• Primary VT- ARVD (RVOT -VT), fascicular VT.
• Secondary VT- 80-90 % of cases of VT.
• Primary and secondary VT in AMI ?
45. Middle aged man , WCT for hrs. together.
IV amiodarone, adenosine – with no effect.
51. Other features of VT
• Extreme axis deviation (“northwest axis”) — QRS is
positive in aVR and negative in I + aVF.
• Brugada’s sign – The distance from the onset of the QRS
complex to the nadir of the S-wave is > 100ms
• Josephson’s sign – Notching near the nadir of the S-wave
• RSR’ complexes with a taller left rabbit ear. This is the most
specific finding in favour of VT. This is in contrast to RBBB,
where the right rabbit ear is taller.
52. Additional factors associated with VT or SVT
• The likelihood of VT is increased with:
• Age > 35 (positive predictive value of 85%)
• Structural heart disease
• Ischaemic heart disease
• Previous MI
• Congestive heart failure
• Cardiomyopathy,
• H/O syncope.
• Family history of sudden cardiac death (suggesting conditions
such as HOCM, congenital long QT syndrome, Brugada
syndrome or arrhythmogenic right ventricular dysplasia(ARVD)
that are associated with episodes of VT)
53. 3. AV dissociation
•The ECG is scrutinised for hidden P waves; these are often superimposed on the
QRS complexes and may be difficult to see.
•If P waves are present at a different rate to the QRS complexes –> AV
dissociation is present and VT is diagnosed.
•If no evidence of AV dissociation can be seen –> go to step 4.
AV dissociation: P waves can be spotted in between QRS complexes (circled)
and superimposed upon the T wave causing a peaked appearance (arrow)
59. Torsade de pointes( Torsad de pont).
• This is a type of short duration tachycardia that reverts to sinus rhythm
spontaneously.
• It may be due to:
- Congenital
- Electrolyte disorders e.g. hypokalemia, hypomagnesemia, hypocalcemia.
- Drugs e.g. tricyclic antidepressant, class IA and III antiarrhythmics.
Quinolone, cispride, antihistamine, clarithromycine.
Toxins- Herbal, Toxic fish.
• It may present with syncopal attacks and occasionally ventricular fibrillation.
• QRS complexes are irregular and rapid that twist around the baseline. In
between the spells of tachycardia the ECG show prolonged QT interval.
61. VF – totally disorganized and bizarre electrical activity.
There is pattern similar to “ torsade de pointes “- torsad de point
VT .
This man collapsed during recording. He was defibrillated, treated
for MI & survive. Don’t try to take 12 lead ECG . It will delay
treatment only .
64. Treatment of TDP
• Correction of any electrolyte disturbances,
• stopping of causative drug,
• Magnesium sulphate 8 mmol (mg2+) over 10-15 min for
acquired long QT,
• IV isoprenaline in acquired cases and B blockers in
congenital types .
• atrial or ventricular pacing @ >70 bpm.
• Long-term management of acquired long QT syndrome
involves avoidance of all drugs known to prolong the QT
interval.
• Congenital long QT syndrome is generally treated by beta-
blockade, left cardiac sympathetic denervation and ICD.
65. Arrhythmia in AMI
• PVC.
• Idioventricular Rhythm- rate <100 bpm. Slow VT. Not related to in
hospital or 1 yr. mortality.
• Non-sustained VT- >3 consequitive PVCs but persist <30 sec.
• 67% cases in AMI- specially in large infarc.
• Sustained VT- 3.5%.
• VF-4%. Both VT and VF in same patient- 2.7%.
• Sustained VT- n hospital mortality 18%.
• VT+VF group-44%.
• 1 yr mortality is also high.
• A.F- Rx ?
• Primary VT- in absence LVF
• Secondary VT- in LVF, electrolyte imbalance.